Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success

Division: Cognigen

On February 11, International Day for Women and Girls in Science 2021, Jill Fiedler-Kelly, President and co-founder of the Cognigen division of Simulations Plus, presented a webinar entitled ‘Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success.’ Jill will discuss factors promoting the effective implementation of modeling and simulation in drug development programs to best position the program for regulatory success and achieve optimal benefit from data-driven and informed internal decision making.

In honor of the International Day of Women and Girls in Science, she will also share and reflect on some of her early career experiences.

By Jill Fiedler-Kelly, Kevin Dykstra

Download Slides